Life Scientist > Biotechnology

LCT updates Diabecell trial

11 February, 2009 by Kate McDonald

Good safety results from Phase I/IIa trial of Diabecell implants


EU for Evibodies

09 February, 2009 by Kate McDonald

Arana receives EU patent for baby antibodies


Medical device briefs

05 February, 2009 by Staff Writers

Nanosonics, Polartechnics, Fluorotechnics


Biotech on the brink

05 February, 2009 by Staff Writers

One in four biotechs in strife – AusBiotech


Glimmer of hope for biotech: PwC

03 February, 2009 by Kate McDonald

Despite 26 per cent drop, PwC says there’s still a glimmer of hope for biotech


Stockpile boost for Biota

02 February, 2009 by Kate McDonald

UK Government stockpiles Relenza


Why locusts become party animals

02 February, 2009 by Kate McDonald

Serotonin levels go sky high in swarming locusts


Clinuvel receives IND status

29 January, 2009 by Kate McDonald

Afamelanotide granted IND status by US FDA


Cytopia enters Progen squabble

28 January, 2009 by Kate McDonald

Cytopia calls for board spill and offers merger for troubled Progen


Phase III positive for Clinuvel

22 January, 2009 by Kate McDonald

Good early results in Phase III trial for sun intolerance drug


Phase II for BioGard

15 January, 2009 by Kate McDonald

Immuron’s BioGard in Phase II trial for HIV


Parkinson’s indication for LCT

11 December, 2008 by Kate McDonald

Rat studies show encapsulated brain cells useful in Parkinson’s model


Arana begins Phase II

11 December, 2008 by Kate McDonald

Multi-centre Phase II trial in rheumatoid arthritis begins


Head and neck for Viralytics

09 December, 2008 by Kate McDonald

Viralytics finds fourth indication for oncolytic virus technology


Promising results for CML

09 December, 2008 by Kate McDonald

ChemGenex compound shows promising results in drug-resistant CML


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd